These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38073438)

  • 1. Advances in the Management of Neuroblastoma.
    Qadir MI; Ahmed B; Noreen S
    Crit Rev Eukaryot Gene Expr; 2024; 34(2):1-13. PubMed ID: 38073438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of high-risk neuroblastoma with intensive chemotherapy, autologous peripheral blood stem cell transplantation, and 13-cis-retinoic acid].
    Tang SQ; Huang DS; Wang JW; Zhang XF; Liu LZ; Yu F; Yang G
    Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):486-9. PubMed ID: 15324562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of neuroblastoma.
    George RE; Diller L; Bernstein ML
    Expert Opin Pharmacother; 2010 Jun; 11(9):1467-78. PubMed ID: 20408767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targets and Antibody Formats for Immunotherapy of Neuroblastoma.
    Park JA; Cheung NV
    J Clin Oncol; 2020 Jun; 38(16):1836-1848. PubMed ID: 32167865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell death-based treatment of neuroblastoma.
    Valter K; Zhivotovsky B; Gogvadze V
    Cell Death Dis; 2018 Jan; 9(2):113. PubMed ID: 29371588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment.
    Seitz CM; Flaadt T; Mezger M; Lang AM; Michaelis S; Katz M; Syring D; Joechner A; Rabsteyn A; Siebert N; Troschke-Meurer S; Zumpe M; Lode HN; Yang SF; Atar D; Mast AS; Scheuermann S; Heubach F; Handgretinger R; Lang P; Schlegel P
    Front Immunol; 2021; 12():690467. PubMed ID: 34367149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of treatment strategies for advanced neuroblastoma.
    Hara J
    Int J Clin Oncol; 2012 Jun; 17(3):196-203. PubMed ID: 22588779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic large cell neuroblastoma.
    Abramowsky CR; Katzenstein HM; Alvarado CS; Shehata BM
    Pediatr Dev Pathol; 2009; 12(1):1-5. PubMed ID: 18397155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology and treatment of neuroblastoma.
    Castleberry RP
    Pediatr Clin North Am; 1997 Aug; 44(4):919-37. PubMed ID: 9286292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation.
    Peinemann F; van Dalen EC; Enk H; Tytgat GA
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012442. PubMed ID: 31016728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
    Tang SQ; Huang DS; Wang JW; Feng C; Yang G
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma: developmental biology, cancer genomics and immunotherapy.
    Cheung NK; Dyer MA
    Nat Rev Cancer; 2013 Jun; 13(6):397-411. PubMed ID: 23702928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
    Owens C; Irwin M
    Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.
    Peinemann F; van Dalen EC; Tushabe DA; Berthold F
    Cochrane Database Syst Rev; 2015 Jan; 1():CD010685. PubMed ID: 25634649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma: clinical and biological approach to risk stratification and treatment.
    Tolbert VP; Matthay KK
    Cell Tissue Res; 2018 May; 372(2):195-209. PubMed ID: 29572647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma: paradigm for precision medicine.
    Irwin MS; Park JR
    Pediatr Clin North Am; 2015 Feb; 62(1):225-56. PubMed ID: 25435121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates in Diagnosis, Management, and Treatment of Neuroblastoma.
    Swift CC; Eklund MJ; Kraveka JM; Alazraki AL
    Radiographics; 2018; 38(2):566-580. PubMed ID: 29528815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.